BRIEF CHEMOIMMUNOTHERAPY RITUXIMAB (R)-FND /- R MAINTENANCE IS EFFECTIVE AND SAFE IN NEWLY DIAGNOSED FOLLICULAR LYMPHOMA ELDERLY PATIENTS: AN INTERGRUPPO ITALIANO LINFOMI (IIL) RANDOMIZED TRIAL